Cargando…
Glycogen synthase kinase 3β represses MYOGENIN function in alveolar rhabdomyosarcoma
MYOGENIN is a member of the muscle regulatory factor family that orchestrates an obligatory step in myogenesis, the terminal differentiation of skeletal muscle cells. A paradoxical feature of alveolar rhabdomyosarcoma (ARMS), a prevalent soft tissue sarcoma in children arising from cells with a myog...
Autores principales: | Dionyssiou, M G, Ehyai, S, Avrutin, E, Connor, M K, McDermott, J C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3944270/ https://www.ncbi.nlm.nih.gov/pubmed/24577092 http://dx.doi.org/10.1038/cddis.2014.58 |
Ejemplares similares
-
Preclinical testing of the glycogen synthase kinase-3β inhibitor tideglusib for rhabdomyosarcoma
por: Bharathy, Narendra, et al.
Publicado: (2017) -
A human Myogenin promoter modified to be highly active in alveolar rhabdomyosarcoma drives an effective suicide gene therapy
por: Pruller, Johanna, et al.
Publicado: (2020) -
Correction: A human Myogenin promoter modified to be highly active in alveolar rhabdomyosarcoma drives an effective suicide gene therapy
por: Pruller, Johanna, et al.
Publicado: (2020) -
The Expression of c-Myb Correlates with the Levels of Rhabdomyosarcoma-specific Marker Myogenin
por: Kaspar, Petr, et al.
Publicado: (2015) -
Glycogen synthase kinase 3β in tumorigenesis and oncotherapy
por: He, Rui, et al.
Publicado: (2020)